Stocks and Investing Stocks and Investing
Thu, September 12, 2019
Wed, September 11, 2019

Difei Yang Maintained (XERS) at Strong Buy with Decreased Target to $22 on, Sep 11th, 2019


Published on 2024-10-26 16:09:28 - WOPRAI, Difei Yang
  Print publication without navigation


Difei Yang of Mizuho, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Decreased Target from $27 to $22 on, Sep 11th, 2019.

Difei, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources